Literature DB >> 31971902

Incidence of Left Atrial Appendage Triggers in Patients With Atrial Fibrillation Undergoing Catheter Ablation.

Mohamed Al Rawahi1, Jackson J Liang2, Suraj Kapa3, Aung Lin1, Yasuhiro Shirai1, Ling Kuo1, Erica S Zado1, Matthew C Hyman1, Michael P Riley1, Saman Nazarian1, Fermin C Garcia1, David Lin1, Robert D Schaller1, Jeffery S Arkles1, David S Frankel1, Gregory E Supple1, Ramanan Kumareswaran1, David J Callans1, Francis E Marchlinski1, Sanjay Dixit4.   

Abstract

OBJECTIVE: This study sought to investigate incidence of left atrial appendage (LAA) triggers of atrial fibrillation (AF) and/or organized atrial tachycardias (OAT) in patients undergoing AF ablation and to evaluate outcomes after ablation.
BACKGROUND: Although LAA isolation is being increasingly performed during AF ablation, the true incidence of LAA triggers for AF remains unclear.
METHODS: All patients with LAA triggers of AF and/or OAT during AF ablation from 2001 to 2017 were included. LAA triggers were defined as atrial premature depolarizations from the LAA, which initiated sustained AF and/or OAT.
RESULTS: Out of 7,129 patients undergoing AF ablation over 16 years, LAA triggers were observed in 21 (0.3%) subjects (age 60 ± 9 years; 57% males; 52% persistent AF). Twenty (95%) patients were undergoing repeat ablation. The LAA was the only nonpulmonary vein trigger in 3 patients; the remaining 18 patients had both LAA and other nonpulmonary vein triggers. LAA triggers were eliminated in all patients (focal ablation in 19 patients; LAA isolation in 2 patients). Twelve months after ablation, 47.6% remained free from recurrent arrhythmia. After overall follow-up of 5.0 ± 3.6 years (median: 3.7 years; interquartile range: 1.4 to 8.9 years), 38.1% were arrhythmia-free. All 3 patients with triggers limited to the LAA remained free of AF recurrence. One patient undergoing LAA isolation developed LAA thrombus during follow-up.
CONCLUSIONS: The incidence of true LAA triggers is very low (0.3%). Most patients with LAA triggers have additional nonpulmonary vein triggers, and despite elimination of LAA triggers, long-term arrhythmia recurrence rates remain high. Potential risks of empiric LAA isolation during AF ablation (especially first-time AF ablation) may outweigh benefits.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ablation; atrial fibrillation; left atrial appendage; triggers

Mesh:

Year:  2019        PMID: 31971902     DOI: 10.1016/j.jacep.2019.08.012

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  4 in total

Review 1.  Catheter ablation for atrial fibrillation: current indications and evolving technologies.

Authors:  Ramanathan Parameswaran; Ahmed M Al-Kaisey; Jonathan M Kalman
Journal:  Nat Rev Cardiol       Date:  2020-10-13       Impact factor: 32.419

2.  Prevalence and Characteristics of Atrial Tachycardia From Noncoronary Aortic Cusp During Atrial Fibrillation Catheter Ablation.

Authors:  Myung-Jin Cha; Jun Kim; Yoon Jung Park; Min Soo Cho; Hyoung-Seob Park; Soonil Kwon; Young Soo Lee; Jinhee Ahn; Hyung-Oh Choi; Jong-Sung Park; YouMi Hwang; Jin Hee Choi; Ki-Won Hwang; Yoo-Ri Kim; Seongwook Han; Seil Oh; Gi-Byoung Nam; Kee-Joon Choi; Hui-Nam Pak
Journal:  Korean Circ J       Date:  2022-04-04       Impact factor: 3.101

3.  Atrial fibrillation evolution and rhythm control strategy following left appendage closure: new insights from the prospective FLAAC registry.

Authors:  Nicolas Lellouche; Raphaele Arrouasse; Julien Ternacle; Romain Gallet; Jean-Sylvain Hermida; David Hamon; Jean-Michel Juliard; Jean-Luc Pasquie; Tarvinder Dhanjal; Emmanuel Teiger; Philippe Le Corvoisier
Journal:  BMC Cardiovasc Disord       Date:  2021-05-03       Impact factor: 2.298

4.  Electrophysiological characteristics of non-pulmonary vein triggers excluding origins from the superior vena cava and left atrial posterior wall: Lessons from the self-reference mapping technique.

Authors:  Yasuharu Matsunaga-Lee; Yasuyuki Egami; Sen Matsumoto; Nobutaka Masunaga; Kohei Ukita; Akito Kawamura; Hitoshi Nakamura; Yutaka Matsuhiro; Koji Yasumoto; Masaki Tsuda; Naotaka Okamoto; Masamichi Yano; Yuzuru Takano; Yasushi Sakata; Masami Nishino; Jun Tanouchi
Journal:  PLoS One       Date:  2022-04-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.